Activation of protease-activated receptor-2 by proteolytic enzymes increases production of transforming growth factor (TGF)-β, and induces a profibrogenic phenotype in human HSCs and promotes hepatic fibrosis in mice [13]. Here, TGFB1 is linked to Hepatic fibrosis.